Dusseldorf - Delayed Quote EUR

Applied DNA Sciences Inc (UDJP.DU)

Compare
4.2600 +4.0470 (+1,900.00%)
As of April 24 at 7:30 PM GMT+2. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
5,517.8720
13,367.4430
18,168.6770
9,027.7380
1,931.4970
--
Cost of Revenue
3,642.8100
7,834.0110
13,115.0370
4,544.8320
827.8230
--
Gross Profit
1,875.0620
5,533.4320
5,053.6400
4,482.9060
1,103.6740
--
Operating Expense
16,312.1680
16,486.7220
19,023.4030
17,009.8060
13,638.6730
--
Operating Income
-14,437.1060
-10,953.2900
-13,969.7630
-12,526.9000
-12,534.9990
--
Net Non Operating Interest Income Expense
116.6830
75.3320
7.2000
13.6750
-115.8300
--
Other Income Expense
1,966.5130
855.0420
5,692.5040
-1,765.2140
-378.0750
--
Pretax Income
-12,353.9100
-10,022.9160
-8,270.0590
-14,278.4390
-13,028.9040
--
Net Income Common Stockholders
-12,500.6910
-9,947.0590
-8,377.9960
-14,286.4420
-13,030.0610
--
Diluted NI Available to Com Stockholders
-12,500.6910
-9,947.0590
-8,377.9960
-14,286.4420
-13,030.0610
--
Basic EPS
-17.63
-15.20
-18.60
-41.40
-66.40
--
Diluted EPS
-17.63
-15.20
-18.60
-41.40
-66.40
--
Basic Average Shares
719.8040
653.7700
448.3850
345.8490
195.9530
--
Diluted Average Shares
719.8040
653.7700
448.3850
345.8490
195.9530
--
Total Operating Income as Reported
-14,437.1060
-10,953.2900
-13,969.7630
-13,348.6410
-12,534.9990
--
Total Expenses
19,954.9780
24,320.7330
32,138.4400
21,554.6380
14,466.4960
--
Net Income from Continuing & Discontinued Operation
-12,267.6040
-9,947.0590
-8,267.8910
-14,286.4420
-13,027.2190
--
Normalized Income
-14,251.9390
-10,801.4590
-14,007.7000
-12,529.9840
-13,027.2190
--
Interest Income
116.6830
75.3320
7.2000
13.6750
--
--
Interest Expense
--
--
--
--
115.8300
162.4320
Net Interest Income
116.6830
75.3320
7.2000
13.6750
-115.8300
--
EBIT
-14,437.1060
-10,953.2900
-13,969.7630
-12,526.9000
-12,534.9990
--
EBITDA
-13,273.0020
-9,591.0410
-12,679.2830
-11,682.4620
-12,249.2690
--
Reconciled Cost of Revenue
3,642.8100
7,834.0110
13,115.0370
4,544.8320
827.8230
--
Reconciled Depreciation
1,164.1040
1,362.2490
1,290.4800
844.4380
285.7300
--
Net Income from Continuing Operation Net Minority Interest
-12,267.6040
-9,947.0590
-8,267.8910
-14,286.4420
-13,027.2190
--
Total Unusual Items Excluding Goodwill
1,984.3350
854.4000
5,739.8090
-1,756.4580
--
--
Total Unusual Items
1,984.3350
854.4000
5,739.8090
-1,756.4580
--
--
Normalized EBITDA
-15,257.3370
-10,445.4410
-18,419.0920
-9,926.0040
-12,249.2690
--
9/30/2019 - 3/5/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade